Clinical Trial Update: Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on rates and reasons for non-adherence to anti-arrhythmic therapy in atrial fibrillation; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Creighton University | Conditions: Atrial Fibrillation, Medication Adherence | Phase 4 | Status: TERMINATED